AGP Executive Report

Your go-to archive of top headlines, summarized for quick and easy reading.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

Medical Cannabis Marketing Scrutiny: Australia’s MOCA admitted it wrongly described its products as TGA-approved, even though most medicinal cannabis goods are not assessed by the regulator—raising fresh alarm about how clinics and online prescribers pitch CBD/THC care. Clinical CBD Progress: Avecho’s cannabidiol insomnia capsule trial moves into a second cohort after an independent board backed continuing enrolment, while Neurotech’s broad-spectrum cannabinoid autism study has dosed its first child in a pivotal “Beyond Harmony” push. Industry Pressure in Massachusetts: A new Q&A explains how Ballot Question 8 could repeal adult-use recreational marijuana sales in the state, despite record sales and a large business footprint. Regulation Updates: Missouri proposed rule changes for cannabis facility licensing and ownership, and Uganda’s government warned investors against diverting licensed medical cannabis and industrial hemp into illicit markets. Workplace Reality: A report notes more workers test positive for cannabis, even as some employers loosen screening—raising liability and workers’ comp concerns. Hemp THC Legal Fight (US): Congress moved to close a loophole that fueled the hemp-THC market, delaying the effective date and setting up a new regulatory fight.

Hemp THC policy fight: A looming federal “hemp THC ban” is threatening the $28B market for impairing hemp products like THC seltzers and smokable flower, with lawmakers pushing to regulate instead of eliminate and a delayed effective date giving the industry a short runway. Medical cannabis marketing crackdown: Australia’s MOCA admitted it wrongly described its medicinal cannabis products as TGA-approved, though most are not regulator-assessed—raising fresh alarm about how clinics pitch CBD/THC products. Veterans and high-THC harm: A Four Corners investigation says for-profit providers aggressively targeted veterans for DVA-funded care, including cases where patients were prescribed huge amounts of high-THC cannabis they never properly discussed with clinicians. Legal/consumer access pressure: Oregon retailers say federal changes could put hemp-derived CBD products out of reach, while North Carolina’s advisory council is weighing THC public-use rules. Courtroom ripple effects: Georgia’s Supreme Court revived a hemp grower’s fight after police allegedly destroyed legal hemp, overturning long-standing government immunity precedent. Public safety & misuse: Reports also highlight cannabis-related psychosis and violent incidents involving daily cannabis use, underscoring ongoing risks around THC products.

Hemp THC policy fight: A looming federal ban on “hemp THC” products (including THC seltzers and smokable flower) is threatening a roughly $28B industry, with advocates pushing for regulation instead of elimination as the effective date shifts to Dec. 11. Public consumption rules: North Carolina’s cannabis advisory council is drafting a THC public-use framework, comparing approaches from Virginia, California, and Colorado as it heads toward a Dec. 31 deadline. Youth health: A large U.S. study links teen cannabis use to slower cognitive development, while a separate report warns one in four school vapes tested positive for illegal substances amid a child vaping “crisis.” Medical/health innovation: St. Joseph’s Healthcare Hamilton secured $2M for a Centre for Health Innovation and Research in Psychedelics to study carefully dosed, medical-grade treatments for conditions including addiction and PTSD. CBD industry support: Cannatrol’s Cool Cure Limited Edition program added Operation Green Healing as an exclusive nonprofit partner supporting veterans and military families.

Hemp THC Crackdown: Oregon retailers and suppliers warn a looming federal ban could wipe out much of the $28B hemp THC market, with operators scrambling as effective dates shift. Farmer Pushback: Minnesota hemp grower Winona LaDuke calls federal hemp rules “punishing” and says CBD-focused restrictions still threaten fiber growers and tribal livelihoods. Medical Access Moves: Georgia’s medical cannabis commission approved delivery rules, aiming to help rural and homebound patients, while Illinois cities like Peoria weigh how to regulate new drive‑thru/curbside options. Policy Feedback: Virginia opened a patient satisfaction survey for its medical cannabis program, seeking gaps and improvements from more than 114,000 prior patients. Public Use Rules: North Carolina’s advisory council is drafting a cannabis public consumption framework for Gov. Josh Stein, using other states as models. Youth & Safety: A large study links teen cannabis use to slower cognitive development, and a UK report says 1 in 4 school vape tests show illegal substances.

Regulatory Overhaul (Albania): Albania rolled out new rules for supervising, tracking, and inspecting licensed cannabis activities across the full supply chain, with the National Cannabis Control Agency using risk-based inspections plus tech-enabled monitoring and 24/7 surveillance access. Medical Access (Georgia): Georgia approved home delivery for registered medical cannabis patients, with USPS as a key delivery route and private carriers potentially joining if approved. Local Zoning (Illinois): Peoria is considering how to regulate drive-thru cannabis after a state law opened the door, with dispensaries likely needing special use approval changes and public hearings. Patient Feedback (Virginia): Virginia launched a medical cannabis patient satisfaction survey to identify what’s working, what’s not, and where gaps remain, closing Oct. 16. Industry/Business (Australia): Cann Group signaled a shift toward pharmaceutical-grade export growth as regulators tighten prescribing, advertising, and product quality scrutiny. Research Watch (Cannabinoids & Brain): A mouse study linked cannabinoid drug exposure to anxiety-related brain activity, pointing to possible targets for reducing anxiety effects. Community & Safety (US): A report said four students at Edison Middle School in Wheaton were treated after suspected marijuana gummy overdoses, prompting 911 calls and secure-teaching measures.

Medical Cannabis Outcomes: Minnesota officials report that among 1,800 autism patients in the state program, many saw clinically meaningful drops in anxiety, depression, and sleep issues after starting medical cannabis. Neuroscience & Safety: A Northwestern study links cannabinoid-triggered anxiety to specific brain neurons, helping explain why some users feel calm then suddenly panic. Patient Feedback Push: Virginia’s Cannabis Control Authority is rolling out a satisfaction survey to learn how patients use medical marijuana and where they get products, aiming to improve the program. Regulatory Watch: Michigan lawmakers are escalating scrutiny of kratom over rising poisonings, while federal cannabis rescheduling faces a pause after process concerns. Industry & Supply Chain: Ireland’s Dunbar Pharma, making plant-derived cannabinoid APIs, is named a finalist for a major start-up founder award. Local Cannabis Policy: Charles County, Maryland approved a temporary moratorium on most cannabis growing zones while it reviews where larger operations should go. Hemp Under Pressure: West Virginia’s Moon Flower warns federal THC restrictions could threaten its hemp business.

Medical Cannabis Access & Regulation: Minnesota’s Office of Cannabis Management met Rochester residents to address rollout concerns, especially public health, packaging/labeling, and keeping products away from kids under 21. Product & Safety Oversight: California’s Department of Cannabis Control is moving to pesticide testing with action levels by individual chemicals, with updated limits and separate standards for inhalable vs non-inhalable products coming next year. Clinical Outcomes: Minnesota reported that autism patients in its medical cannabis program saw drops in anxiety and depression after starting treatment. Industry Expansion: Curaleaf says its TGA-registered liquid medical cannabis inhalation device is now available in Australia and also added to New Zealand’s device database. Market & Legal Pressure: A Missouri judge denied Good Day Farm’s bid to dismiss a customer lawsuit alleging it reduced competition and kept prices high, allowing an amended complaint. Policy Debate: Idaho voters will decide whether the legislature—not ballot initiatives—controls future marijuana and drug law changes. Enforcement & Crime: Europol launched a taskforce targeting rising cannabis smuggling into Europe from North America and Thailand. Community & Philanthropy: Cannatrol’s Cool Cure Limited Edition program added Operation Green Healing as a nonprofit partner supporting veterans and military families.

Medical Access & Policy: Pennsylvania’s “Ryan’s Law” cleared a Senate panel, aiming to let terminally ill hospital patients use medical cannabis (no smoking/vaping) even outside hospice protocols. Veterans Research: A bipartisan U.S. bill would require VA studies on cannabis for veterans with PTSD and chronic pain. State Rules & Safety: Missouri filed proposed cannabis ownership and recall rule updates, including clearer ownership-change rules and recall procedures. Georgia Delivery Update: Regulators approved medical marijuana delivery rules that could include USPS and private carriers, with signature/proof-of-delivery requirements. Product Labeling: California signed new packaging and labeling requirements for THC edibles and drinks, including Poison Help line info and clearer multi-serving dosing instructions. Clinical Findings: Minnesota’s real-world study in autism patients reported reduced anxiety and depression within four months of medical cannabis use. CBD & Sleep: A new report highlights CBD’s potential sleep benefits, while noting more research is still needed. Public Consumption: North Carolina’s cannabis council previewed how a THC public consumption framework could work.

Medicinal Cannabis Funding: NZX-listed Rua Bioscience opened a $2.8m three-for-one renounceable rights offer to build inventory and fund working capital after a major export deal. Care Access via Captive Benefits: Blackwell Captive Solutions partnered with Apta Health to roll out Apta Cash, a guided cash-pay care option for employers in its cannabis-focused captive network. Medical Cannabis in Practice: Ukraine’s health ministry says a female cancer patient in Mykolaiv received medical cannabis-based medication for the first time, via electronic prescription and recorded dispensing. Clinical Safety Signal (Epilepsy): A new study in Epilepsia links frequent cannabis use (at least 20 days/month) with more severe seizures and faster resistance to antiseizure meds in drug-resistant epilepsy patients. Regulatory/Enforcement: Montgomery County (MD) advanced charges against 46 businesses for selling illegal THC products, while Wisconsin lawmakers moved to remove Flock license-plate reader cameras from county parks. Product/Manufacturing Update: Dunbar Pharma confirmed UK specialist prescribers can now access plant-derived dronabinol oral sprays via IPS Pharma. Industry Ownership: Australia’s Tasmanian Botanics is now almost fully Chinese-owned after Yongji Health bought remaining shares.

Regulatory Crackdown on Illegal THC: Montgomery County prosecutors filed felony charges against nearly 50 businesses, alleging they sold potent hemp-derived THC vapes, gummies, and edibles outside Pennsylvania’s medical dispensary system. Local Cannabis Rollouts: Ellsworth, Maine approved three adult-use cannabis shops nearly two years after voters OK’d the plan, with construction underway for at least two. Zoning Pressure on Grow Ops: Charles County, Maryland approved a one-year moratorium on most cannabis farming while it updates zoning rules. Public Safety & Health Signals: A UC San Diego analysis found about 1 in 9 older cannabis users (65+) met criteria for cannabis use disorder, mostly mild. Enforcement in Michigan: Michigan regulators revoked 20 medical grow licenses and fined GP Holdings $2M after packages were allegedly identified as marijuana flower but contained no THC. Industry & Tech: Oscity BioSciences acquired Enantia’s cannabinoid cocrystal patents to expand pharmaceutical-focused production. Corporate Funding: NZ medicinal cannabis firm Rua Bioscience launched a $2.8M rights offer to fund inventory for export demand.

Public Health & Policy: Massachusetts voters are lining up to keep legal recreational marijuana, with a new MassINC Polling Group survey showing 61% oppose Question 8, which would end regulated sales and add civil penalties. Medical Access: Pennsylvania’s Senate committee advanced a bill letting terminally ill patients use medical cannabis in hospitals and long-term care (no smoking/vaping; facilities must set guidelines). Treatment Research: A small randomized trial suggests an experimental combo (nabilone + gabapentin) may ease cannabis withdrawal symptoms, but researchers warn larger studies are needed. Regulatory Transparency: A new study links state-issued cannabis QR codes to higher consumer trust and confidence in legal markets. Industry & Markets: Oregon CBD Company plans to close its hemp product shop after a new federal law would ban most of its items, while Oregon’s dispensary side remains open. CBD Market Outlook (EU): EFSA’s first positive CBD opinion signals progress, but strict rules still limit growth. Local Business: A new licensed cannabis shop is approved in Geneva, New York.

Youth Protection Push: Trinidad and Tobago’s PM Kamla Persad-Bissessar says new legislation will raise the legal age for alcohol and tobacco to 21, and for cannabis (and gambling) to 25, aiming to curb early substance exposure. Courtroom Fight Over Licenses: Missouri’s Supreme Court heard a challenge to cannabis facility licensing after an audit alleged flaws in how applications were scored, with a company arguing inconsistent grading. Health Warning on Vapes: A systematic review in Nature links childhood vaping to a wider set of risks than expected, including nicotine dependence, respiratory/oral problems, mental health issues, and later cigarette use. Product Safety Recall: Colorado recalled certain cannabis vape products after methylene chloride contamination was found, with affected items sold across multiple dispensaries. Seizure Concerns: New research reports frequent cannabis use is associated with about double the seizure risk, and separate findings in drug-resistant epilepsy suggest more convulsive seizures among frequent users. Medical Market Updates: Ohio’s Division of Cannabis Control ordered a Jackson dispensary to close during an investigation into serious adverse events; it later reopened after testing found no contaminants. Business Deal: Trulieve announced an exclusive master licensing agreement with Connected for Alien Labs and Connected branded products in Florida and Texas. Older-Adult Use Disorder: A study finds a notable share of older adults who use cannabis meet criteria for cannabis use disorder, with risk rising alongside heavier use.

Policy Push: Trinidad and Tobago’s PM says a new bill aims to tighten protections for young people by curbing alcohol, tobacco, cannabis and gambling risks. Vet Safety: A New York veterinarian reports a sharp rise in pets ingesting THC gummies, with symptoms like balance issues and possible seizures—urging safer storage. Brand Accountability: New York’s Silly Nice leans into transparency, spotlighting founders and lab results as the state’s cannabis market gets more crowded. Medical Caution: Multiple studies link frequent cannabis use with worse epilepsy outcomes—more convulsive seizures and faster resistance to antiseizure meds—plus new work finds cannabis use disorder is common among older adults. Regulation & Product Safety: California signed bills tightening marijuana testing, lab performance checks, and consumer access to certificates of analysis; Colorado recalled certain vape products after methylene chloride contamination. Hemp THC Crackdown: Pennsylvania GOP Sen. Dawn Keefer proposes age limits and testing for hemp THC products. Enforcement & Equity: Virginia youth advocates warn higher public-marijuana fines could deepen racial disparities as enforcement shifts toward schools. Industry Deal: Trulieve announced an exclusive master licensing agreement with Connected for Alien Labs and Connected brands in Florida and Texas.

Medicinal Cannabis Oversight: Jersey officials say they can’t intervene in UK doctors’ prescribing after a death linked to medicinal cannabis exposed oversight gaps, including limited access to patient records and weak “responsible officer” coverage. Regulatory Watch: The FDA’s long-running fight over supplements resurfaces with NAC, highlighting how ingredients previously approved as drugs can get stuck in supplement rulemaking delays—an issue that echoes the broader CBD/medical-cannabis regulatory climate. Clinical Safety: A cannabis physician warns about possible interactions with GLP-1 weight-loss drugs, noting both can slow stomach emptying and may worsen nausea or vomiting in some patients. Market & Corporate Moves (ASX): Little Green Pharma’s LGP-Cannatrek merger heads into its first full-quarter test as it funds European expansion while managing a regulatory penalty overhang; Vitura Health faces telehealth referral pipeline pressure; Cann Group leans on early UK export momentum; Epsilon Healthcare touts a renewed higher-capacity manufacturing permit; Neurotech reshapes leadership as its cannabinoid program advances. Policy & Access: Arkansas dispensaries expect federal medical-marijuana rescheduling to improve tax treatment, while state-level rules may still shift operations. Drug Abuse Context: Mozambique reports a sharp rise in drug-related mental health cases, with cannabinoids among the listed drivers.

Federal rescheduling impact: Arkansas dispensaries say new federal medical marijuana rescheduling could cut taxes and change operations, as patient demand rises while sales shift. Product safety alert: Colorado regulators warned that some marijuana vapes sold at 405 dispensaries contain methylene chloride, urging consumers not to use the contaminated products. Clinical caution: A doctor flagged possible interactions between cannabis and GLP-1 weight-loss drugs, noting both can slow stomach emptying and may worsen nausea/vomiting for some. Access expansion: Minnesota’s Coconut Cannabis is preparing to move into the medical market, aiming to reduce long drives for patients in a “medical desert.” Regulatory pressure on psychedelics: Oregon backed off proposed fee hikes for its adult psilocybin program after industry pushback. Local policy push: Virginia localities may add a 1%–3.5% cannabis tax for K-12, public health, economic opportunity, and substance-abuse prevention. Public health debate: A Canadian road-safety report found a growing share of fatal crashes involve drivers testing positive for drugs (not necessarily impairment).

Colorado Cannabis Safety: Colorado regulators issued a health advisory after methylene chloride was found in marijuana vapes sold at 405 dispensaries, following reporting on delays in expanded testing. Prison Drug Control: NSW police charged two men after an alleged drone attempt to drop cannabis and other contraband into a prison in Cooma, with a similar earlier incident at Goulburn Supermax. Criminal Justice & Cannabis: Morrison County (Minnesota) says legalization cut probation caseloads but is creating new work for officers as more DWI cases involve open marijuana and medical prescriptions complicate supervision. Youth Prevention: A Guam middle school mural campaign pushed “Be Tough, Don’t Puff!” to discourage vaping and underage cannabis use through art. Medical Access Expansion: Bemidji, Minnesota’s Coconut Cannabis is preparing to add medical marijuana services, aiming to reduce long-distance travel for patients. Policy Watch: Oregon psilocybin regulators backed off proposed fee hikes after industry pushback, keeping licensing costs from doubling. Research & Discovery: South African scientists report rare flavoalkaloids in commercial cannabis leaves, suggesting underused plant material may hold new medical potential.

Medical Access Expansion: A new Minnesota dispensary, Coconut Cannabis in Bemidji, is preparing to open its doors to medical marijuana patients, aiming to cut down long drives for people in a “medical desert.” Legal & Public Safety: In Morrison County, community corrections says adult-use legalization has reduced probation caseloads tied to cannabis, but has also complicated DWI supervision when drivers have “open marijuana,” adding extra verification work. Criminal Justice: NSW police charged two men after an alleged drone attempt to drop cannabis and other contraband into a prison in Cooma, following similar thwarted drone incidents. Road Safety: A Canadian traffic-safety report found 41.2% of 2023 road deaths involved at least one drug-positive driver (including cannabis), while stressing that a positive test doesn’t prove impairment or cause. Research & Policy: A South African study reported rare flavoalkaloids in commercial cannabis leaves, pointing to new potential compounds beyond cannabinoids.

Prison & Enforcement: NSW police charged two men after an alleged drone attempt to drop contraband into a Cooma prison—police say the package included cannabis, tobacco, phones and SIM cards, following a similar Goulburn Supermax interception earlier in September. Legalization Impact: In Minnesota, teen cannabis use keeps falling after legalization, but disparities remain for some groups; in Morrison County, marijuana legalization cut probation caseloads while complicating DWI supervision when drivers have open marijuana. Medical & Policy: A U.S. rescheduling update highlights how certain FDA-approved and state-licensed medical marijuana products moved from Schedule I to Schedule III, while broader federal rescheduling questions still aren’t settled. Product Safety: Colorado’s StayCon recalled contaminated marijuana vapes after methylene chloride was found, pointing to testing delays and regulatory gaps. Science & Health Potential: South African researchers report rare flavoalkaloids in cannabis leaves, suggesting underused plant material may hold new medical chemistry leads. Community & Compliance: Massachusetts regulators issued an advertising compliance bulletin clarifying obligations for marijuana establishments under new state rules.

Regulatory Compliance: Michigan regulators flagged tracking, sales, waste disposal, security and disclosure violations in August enforcement actions, underscoring ongoing scrutiny of the state’s cannabis supply chain. Product Safety: Colorado marijuana vapes were voluntarily recalled after contamination with methylene chloride, with regulators still delayed on expanded testing alerts. Adult-Use Politics: Massachusetts voters overwhelmingly oppose a ballot measure to roll back recreational marijuana legalization, with 71% planning to vote no. Medical Access: Massachusetts Gov. Maura Healey proposed letting veterans qualify for the state medical cannabis program using VA documentation without a doctor’s recommendation. Public Health & Use: A New York City survey of adults 65+ found 22.2% used cannabis in the past year, with adverse effects common and many meeting criteria for cannabis use disorder. International Enforcement: Hong Kong Customs seized about 6kg of suspected cannabis buds at the airport and arrested two traffickers. Education for Veterans: Silly Nice launched “THE FIELD MANUAL” to provide evidence-first cannabis information tailored to U.S. veterans. Hemp/THC Crackdowns: Georgia shut down vape and smoke shops selling illegal THC products that were falsely labeled as hemp.

Medical Cannabis Outcomes: A new Minnesota study reports cancer patients in the state’s medical cannabis program are seeing symptom relief, including nausea, vomiting, appetite loss, and even depression/anxiety symptoms, based on more than 6,600 patients. CBD Product Race in Australia: Avecho is in focus as an unlisted rival seeks fast-track TGA registration for a CBD pain tablet despite missing efficacy in a trial, keeping pressure on the push for the first registered CBD pharmacy medicine. Medicinal Market Pricing Pressure: ECS Botanics is spotlighted as rising unemployment and expected rate hikes squeeze patient budgets, with medicinal cannabis prescriptions largely paid out of pocket. Regulatory Crackdown (THC Retail): Texas DPS says it raided 13 Scorpion Smoke Shop locations, seizing suspected THC products, marijuana, and psilocybin mushrooms, citing state rules that limit consumable THC products to below 0.3%. Policy Shift Abroad: Thailand’s cabinet approved a Cannabis Control Bill to move toward medical-only rules, with licensing across the supply chain and advertising restrictions. Safety/Health Angle: A cardiologist warns that inhaled combustible cannabis can raise heart attack and stroke risk, while vaping is also flagged for cardiovascular harm. Local Governance: Maryland counties, including Caroline County, are getting updated guidance on how cannabis tax funds can be used under the Community Reinvestment and Repair Fund.

Sign up for:

Cannabidiol Healthcare News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Cannabidiol Healthcare News

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.